First-in-class positron emission tomography tracer for the glucagon receptor

ABSTRACT: The glucagon receptor (GCGR) is emerging as an important target in anti-diabetic therapy, especially as part of the pharmacology of dual glucagon-like peptide-1/glucagon (GLP-1/GCG) receptor agonists. However, currently, there are no suitable biomarkers that reliably demonstrate GCG recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Velikyan, Irina, Haack, Torsten, Bossart, Martin, Evers, Andreas, Laitinen, Iina, Larsen, Philip, Plettenburg, Oliver, Johansson, Lars, Pierrou, Stefan, Wagner, Michael, Eriksson, Olof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377692/
https://www.ncbi.nlm.nih.gov/pubmed/30771019
http://dx.doi.org/10.1186/s13550-019-0482-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377692/
https://www.ncbi.nlm.nih.gov/pubmed/30771019
http://dx.doi.org/10.1186/s13550-019-0482-0

Ejemplares similares